Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
advisory, assign, back, burn, Codification, CODM, culture, DCF, discipline, disciplined, disposal, driver, embedded, excellence, exit, front, gearing, lending, lot, macro, Maker, nucleotide, orderly, partner, polymorphism, proposition, relax, remeasurement, rental, reorganized, shown, sublease, subtracting, Sweden, therewith, titled, treated, unintended, unobservable, upgrading, write
Filing tables
Filing exhibits
Related press release
Associated LAB transcripts
LAB similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Michael Egholm, the Chief Executive Officer of Standard BioTools Inc. (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,
1.the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 9, 2022 | By: | /s/ Michael Egholm | ||||||
| Michael Egholm | ||||||||
| President and Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||